Joint analysis of PK and immunogenicity outcomes using factorization model − a powerful approach for PK similarity study

por Haliduola, Halimu N., Berti, Fausto, Stroissnig, Heimo, Guenzi, Eric, Otto, Hendrik, Sattar, Abid, Mansmann, Ulrich
Publicado 2022

Assessing the Interchangeability of AVT02 and Humira(®) in Participants with Moderate‑to‑Severe Chronic Plaque Psoriasis: Pharmacokinetics, Efficacy, Safety, and Immunogenicity Res...

por Feldman, Steven R., Kay, Richard, Reznichenko, Nataliya, Sobierska, Joanna, Dias, Roshan, Otto, Hendrik, Haliduola, Halimu N., Sattar, Abid, Ruffieux, Ruth, Stroissnig, Heimo, Berti, Fausto
Publicado 2023

Efficacy, Safety and Immunogenicity of AVT02 Versus Originator Adalimumab in Subjects with Moderate to Severe Chronic Plaque Psoriasis: A Multicentre, Double-Blind, Randomised, Par...

por Feldman, Steven R., Reznichenko, Nataliya, Pulka, Grazyna, Kingo, Külli, George Galdava, Berti, Fausto, Sobierska, Joanna, Dias, Roshan, Guenzi, Eric, Hendrik Otto, Haliduola, Halimu N., Kay, Richard, Stroissnig, Heimo
Publicado 2021